Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome

E. Froňková, A. Klocperk, M. Svatoň, M. Nováková, M. Kotrová, J. Kayserová, T. Kalina, P. Keslová, F. Votava, H. Vinohradská, T. Freiberger, E. Mejstříková, J. Trka, A. Sedivá,

. 2014 ; 9 (12) : e114514. [pub] 20141208

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT13287 MZ0 CEP Register

UNLABELLED: DiGeorge syndrome (DGS) presents with a wide spectrum of thymic pathologies. Nationwide neonatal screening programs of lymphocyte production using T-cell recombination excision circles (TREC) have repeatedly identified patients with DGS. We tested what proportion of DGS patients could be identified at birth by combined TREC and kappa-deleting element recombination circle (KREC) screening. Furthermore, we followed TREC/KREC levels in peripheral blood (PB) to monitor postnatal changes in lymphocyte production. METHODS: TREC/KREC copies were assessed by quantitative PCR (qPCR) and were related to the albumin control gene in dry blood spots (DBSs) from control (n = 56), severe immunodeficiency syndrome (SCID, n = 10) and DGS (n = 13) newborns. PB was evaluated in DGS children (n = 32), in diagnostic samples from SCID babies (n = 5) and in 91 controls. RESULTS: All but one DGS patient had TREC levels in the normal range at birth, albeit quantitative TREC values were significantly lower in the DGS cohort. One patient had slightly reduced KREC at birth. Postnatal DGS samples revealed reduced TREC numbers in 5 of 32 (16%) patients, whereas KREC copy numbers were similar to controls. Both TREC and KREC levels showed a more pronounced decrease with age in DGS patients than in controls (p < 0.0001 for both in a linear model). DGS patients had higher percentages of NK cells at the expense of T cells (p < 0.0001). The patients with reduced TREC levels had repeated infections in infancy and developed allergy and/or autoimmunity, but they were not strikingly different from other patients. In 12 DGS patients with paired DBS and blood samples, the TREC/KREC levels were mostly stable or increased and showed similar kinetics in respective patients. CONCLUSIONS: The combined TREC/KREC approach with correction via control gene identified 1 of 13 (8%) of DiGeorge syndrome patients at birth in our cohort. The majority of patients had TREC/KREC levels in the normal range.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010670
003      
CZ-PrNML
005      
20190702093030.0
007      
ta
008      
160408s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0114514 $2 doi
024    7_
$a 10.1371/journal.pone.0114514 $2 doi
035    __
$a (PubMed)25485546
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Froňková, Eva, $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $d 1977- $7 xx0105058
245    14
$a The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome / $c E. Froňková, A. Klocperk, M. Svatoň, M. Nováková, M. Kotrová, J. Kayserová, T. Kalina, P. Keslová, F. Votava, H. Vinohradská, T. Freiberger, E. Mejstříková, J. Trka, A. Sedivá,
520    9_
$a UNLABELLED: DiGeorge syndrome (DGS) presents with a wide spectrum of thymic pathologies. Nationwide neonatal screening programs of lymphocyte production using T-cell recombination excision circles (TREC) have repeatedly identified patients with DGS. We tested what proportion of DGS patients could be identified at birth by combined TREC and kappa-deleting element recombination circle (KREC) screening. Furthermore, we followed TREC/KREC levels in peripheral blood (PB) to monitor postnatal changes in lymphocyte production. METHODS: TREC/KREC copies were assessed by quantitative PCR (qPCR) and were related to the albumin control gene in dry blood spots (DBSs) from control (n = 56), severe immunodeficiency syndrome (SCID, n = 10) and DGS (n = 13) newborns. PB was evaluated in DGS children (n = 32), in diagnostic samples from SCID babies (n = 5) and in 91 controls. RESULTS: All but one DGS patient had TREC levels in the normal range at birth, albeit quantitative TREC values were significantly lower in the DGS cohort. One patient had slightly reduced KREC at birth. Postnatal DGS samples revealed reduced TREC numbers in 5 of 32 (16%) patients, whereas KREC copy numbers were similar to controls. Both TREC and KREC levels showed a more pronounced decrease with age in DGS patients than in controls (p < 0.0001 for both in a linear model). DGS patients had higher percentages of NK cells at the expense of T cells (p < 0.0001). The patients with reduced TREC levels had repeated infections in infancy and developed allergy and/or autoimmunity, but they were not strikingly different from other patients. In 12 DGS patients with paired DBS and blood samples, the TREC/KREC levels were mostly stable or increased and showed similar kinetics in respective patients. CONCLUSIONS: The combined TREC/KREC approach with correction via control gene identified 1 of 13 (8%) of DiGeorge syndrome patients at birth in our cohort. The majority of patients had TREC/KREC levels in the normal range.
650    _2
$a mladiství $7 D000293
650    _2
$a biotest $7 D001681
650    _2
$a kultivované buňky $7 D002478
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a kruhová DNA $x genetika $7 D004270
650    _2
$a DiGeorgeův syndrom $x diagnóza $x genetika $x imunologie $7 D004062
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a syndromy imunologické nedostatečnosti $x diagnóza $x genetika $x imunologie $7 D007153
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    12
$a novorozenecký screening $7 D015997
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a těžká kombinovaná imunodeficience $x diagnóza $x genetika $x imunologie $7 D016511
650    _2
$a T-lymfocyty $x imunologie $7 D013601
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Klocperk, Adam $u Department of Immunology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Svatoň, Michael $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Nováková, Michaela $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $7 xx0211356
700    1_
$a Kotrová, Michaela $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $7 xx0209776
700    1_
$a Kayserová, Jana, $u Department of Immunology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $d 1978- $7 xx0118295
700    1_
$a Kalina, Tomáš, $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $d 1975 říjen 11.- $7 xx0060125
700    1_
$a Keslová, Petra $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $7 xx0081400
700    1_
$a Votava, Felix, $u Department of Pediatrics, 3rd Medical School, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic. $d 1957- $7 xx0060357
700    1_
$a Vinohradská, Hana, $u Department of Clinical Biochemistry, Children Hospital, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic. $d 1960- $7 xx0224599
700    1_
$a Freiberger, Tomáš $u Department of Clinical Immunology and Allergology, Medical Faculty, and Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Molecular Genetics Lab, Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic. $7 xx0071641
700    1_
$a Mejstříková, Ester, $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $d 1977- $7 xx0105223
700    1_
$a Trka, Jan, $u CLIP, Department of Paediatric Haematology/Oncology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $d 1966- $7 xx0036261
700    1_
$a Šedivá, Anna, $u Department of Immunology, 2nd Medical School, Charles University Prague and University Hospital Motol, Prague, Czech Republic. $d 1955- $7 xx0000191
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 12 (2014), s. e114514
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25485546 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20190702093218 $b ABA008
999    __
$a ok $b bmc $g 1114099 $s 935038
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 12 $d e114514 $e 20141208 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
GRA    __
$a NT13287 $p MZ0
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...